Skip to main content
. 2021 Mar 8;15:1041–1054. doi: 10.2147/OPTH.S296510

Table 5.

DED Questionnaires in the Pre- and Post-Index Periods

Pre-Index n=600 3-Months (± 30 Days) Post-Index n=571 6-Months (± 30 Days) Post-Index n=534 12-Months (± 60 Days) Post-Index n=320
5-Item Dry Eye Questionnaire (DEQ-5) score [0–22]
Patients with documentation of symptom score, n (% [95% CI]) 77 (12.8 [10.3, 15.8]) 10 (1.8 [0.8, 3.2]) 12 (2.2 [1.2, 3.9]) 14 (4.4 [2.4, 7.2])
 Mean ± SD [median] (95% CI of mean) 14.3 ± 4.2 [15.0] (13.3, 15.2) 9.8 ± 5.8 [9.0] (5.7, 13.9) 7.4 ± 4.8 [6.0] (4.4, 10.4) 6.5 ± 4.2 [6.0] (4.1, 8.9)
Ocular Surface Disease Index (OSDI) score [0–100]
Patients with documentation of symptom score, n (% [95% CI]) 54 (9.0 [6.8, 11.6]) 6 (1.1 [0.4, 2.3]) 6 (1.1 [0.4, 2.4]) 8 (2.5 [1.1, 4.9])
 Mean ± SD [median] (95% CI of mean) 60.5 ± 24.8 [65.5] (53.8, 67.3) 31.3 ± 17.8 [25.0] (12.6, 50.0) 41.8 ± 23.7 [35.0] (17.0, 66.7) 28.8 ± 17.3 [25.0] (14.3, 43.2)
Standardized Patient Evaluation of Eye Dryness (SPEED) questionnaire score [0–28]
Patients with documentation of symptom score, n (% [95% CI]) 37 (6.2 [4.4, 8.4]) 5 (0.9 [0.3, 2.0]) 4 (0.7 [0.2, 1.9]) 7 (2.2 [0.9, 4.5])
 Mean ± SD [median] (95% CI of mean) 17.5 ± 5.4 [20.0] (15.7, 19.3) 12.2 ± 3.3 [12.0] (8.0, 16.4) 6.8 ± 3.3 [7.0] (1.5, 12.0) 7.7 ± 5.0 [5.0] (3.1, 12.4)
No symptom questionnaire reported, n (% [95% CI]) 383 (63.8 [59.8, 67.7]) 539 (94.4 [92.2, 96.1]) 497 (93.1 [90.6, 95.1]) 281 (87.8 [83.7, 91.2])

Abbreviations: CI, confidence interval; DED, dry eye disease; SD, standard deviation.